Fosavance 70 mg / 5600 IU Tablets is a combination medication manufactured by Organon LLC for the treatment of osteoporosis. It combines alendronic acid (a bisphosphonate that inhibits bone resorption) with cholecalciferol (Vitamin D3), which is essential for calcium absorption and maintaining healthy bone mineral density.

Indications: Fosavance 70 mg / 5600 IU is used for:

• Treatment of postmenopausal osteoporosis in women at risk of Vitamin D insufficiency

• Treatment of osteoporosis in men at increased risk of fractures

• Reduction of the risk of vertebral and hip fractures

• Ensuring adequate weekly Vitamin D3 supply alongside bisphosphonate therapy

Reasons for Use:

• Low bone mineral density and increased bone fragility

• Established risk or present insufficiency of Vitamin D3

• Prevention of osteoporotic fractures

• Convenient once-weekly oral administration schedule

Key Features:

• Active ingredients per tablet: Alendronic acid 70 mg (as alendronate sodium trihydrate) and Cholecalciferol (Vitamin D3) 140 micrograms (5600 IU)

• Inhibits osteoclast-mediated bone resorption while promoting bone mineralization

• Supplies a weekly dose of 5600 IU Vitamin D3 to support calcium homeostasis

• Convenient pack of 4 tablets (1 month of weekly therapy)

• Manufactured to global standards by Organon LLC, USA

Dosage Form: Fosavance — Tablets, 70 mg / 5600 IU (pack of 4 tablets)

Manufacturer: Organon LLC, USA

Active Ingredients:

• Alendronic acid — 70 mg

• Cholecalciferol (Vitamin D3) — 140 mcg (5600 IU)

#Fosavance #Alendronate #VitaminD3 #Organon #OsteoporosisTreatment #BoneHealth #FracturePrevention #IsraeliMeds #PharmacyIsrael